{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:11:29Z","timestamp":1792649489544,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Standard modifiable risk factors (SMuRFs), including hypertension, diabetes, hyperlipidaemia, and smoking, are prevalent among patients undergoing percutaneous coronary intervention (PCI). This study aimed to assess the prevalence and impact of controlled SMuRFs in patients undergoing PCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data of patients who underwent PCI at a single tertiary-care centre between 2012 and 2023 were analysed. SMuRF control was assessed using pre-procedural measurements: systolic blood pressure &amp;lt;140\u2005mmHg, fasting glucose &amp;lt;126\u2005mg\/dL or a haemoglobin A1c &amp;lt; 7%, low-density lipoprotein &amp;lt;100\u2005mg\/dL, and smoking status (non-smoker). Patients were stratified by the number of controlled risk factors (CRF): 4, 3, 2, and \u22641. The primary outcome was major adverse cardiovascular events (MACE), a composite of all-cause mortality, myocardial infarction, and stroke, at one-year post-PCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 19 651 patients, 5876 (29.9%) had 4-CRF, 8199 (41.7%) had 3-CRF, 4415 (22.5%) had 2-CRF, and 1161 (5.9%) had \u22641-CRF. Compared with 4-CRF, the risk for MACE increased progressively with fewer controlled risk factors (3-CRF: adjHR 1.17, 95% CI 0.98\u20131.40; 2-CRF: adjHR 1.39, 95% CI 1.14\u20131.69; \u22641-CRF: adjHR 1.48, 95% CI 1.10\u20132.00). Glycaemic control had the most significant association with lower MACE (adjHR 0.56, 95% CI 0.49\u20130.65).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Comprehensive SMuRF control before PCI remains infrequent, though it is associated with lower MACE rates. Prioritizing glycaemic control may yield the greatest benefit in improving post-PCI prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag254","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:26:13Z","timestamp":1777638373000},"source":"Crossref","is-referenced-by-count":2,"title":["Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-3361","authenticated-orcid":false,"given":"Johny","family":"Nicolas","sequence":"first","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]},{"name":"Department of Biomedical Sciences, Humanitas University , Pieve Emanuele ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cohen","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-9409","authenticated-orcid":false,"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F","family":"Smith","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6555","authenticated-orcid":false,"given":"Francesca Maria","family":"Di Muro","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]},{"name":"Department of Medicine, Surgery and Dentistry, University of Salerno , Salerno 84081 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-403X","authenticated-orcid":false,"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-5873","authenticated-orcid":false,"given":"Amit","family":"Hooda","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Sharma","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-1632","authenticated-orcid":false,"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Stefanini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , Pieve Emanuele ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-3307","authenticated-orcid":false,"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7502-8049","authenticated-orcid":false,"given":"George","family":"Dangas","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-0793","authenticated-orcid":false,"given":"Samin K","family":"Sharma","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[{"name":"Center for Interventional Cardiovascular Research and Clinical Trials, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, NewYork, NY 10029-6574 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026060107365276400_ehag254-B1","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"2026060107365276400_ehag254-B2","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/ije\/dyv346","article-title":"II. Coronary heart disease in the Framingham study","volume":"44","author":"Dawber","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2026060107365276400_ehag254-B3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"2026060107365276400_ehag254-B4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"key":"2026060107365276400_ehag254-B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jama.1995.03530020049031","article-title":"Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study","volume":"274","author":"Verschuren","year":"1995","journal-title":"JAMA"},{"key":"2026060107365276400_ehag254-B6","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B7","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1093\/eurheartj\/ehad616","article-title":"Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study","volume":"44","author":"Ki","year":"2023","journal-title":"Eur Heart J"},{"key":"2026060107365276400_ehag254-B8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-022-01460-5","article-title":"Diabetes and restenosis","volume":"21","author":"Wilson","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026060107365276400_ehag254-B9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12944-019-0979-6","article-title":"Assessment of the LDL-C\/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation","volume":"18","author":"Zhong","year":"2019","journal-title":"Lipids Health Dis"},{"key":"2026060107365276400_ehag254-B10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"key":"2026060107365276400_ehag254-B11","first-page":"545","article-title":"Surgeon General's report on the health benefits of smoking cessation","volume":"105","author":"Novello","year":"1990","journal-title":"Public Health Rep"},{"key":"2026060107365276400_ehag254-B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"2026060107365276400_ehag254-B13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"2026060107365276400_ehag254-B14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1161\/ATVBAHA.118.310958","article-title":"Novel antiatherosclerotic therapies","volume":"39","author":"Libby","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026060107365276400_ehag254-B15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ehjcvp\/pvaf012","article-title":"New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024","volume":"11","author":"Tamargo","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026060107365276400_ehag254-B16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B17","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"85","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B18","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1016\/j.jacc.2018.06.082","article-title":"Clinician\u2019s guide to reducing inflammation to reduce atherothrombotic risk: JACC review topic of the week","volume":"72","author":"Ridker","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B19","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"2026060107365276400_ehag254-B20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B21","doi-asserted-by":"publisher","first-page":"e0250801","DOI":"10.1371\/journal.pone.0250801","article-title":"Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: implications for primary prevention","volume":"16","author":"Gurm","year":"2021","journal-title":"PLoS One"},{"key":"2026060107365276400_ehag254-B22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2026060107365276400_ehag254-B23","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"2026060107365276400_ehag254-B24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/hrt.2010.213710","article-title":"Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe","volume":"97","author":"Cacoub","year":"2011","journal-title":"Heart"},{"key":"2026060107365276400_ehag254-B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ahj.2022.05.015","article-title":"National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: insights from National Ambulatory Medical Care Survey","volume":"252","author":"Minhas","year":"2022","journal-title":"Am Heart J"},{"key":"2026060107365276400_ehag254-B26","doi-asserted-by":"publisher","first-page":"e2251156","DOI":"10.1001\/jamanetworkopen.2022.51156","article-title":"Trends in provision of medications and lifestyle counseling in ambulatory settings by gender and race for patients with atherosclerotic cardiovascular disease, 2006\u20132016","volume":"6","author":"Mufarreh","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026060107365276400_ehag254-B27","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/eurheartj\/ehae299","article-title":"Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry","volume":"45","author":"Roger","year":"2024","journal-title":"Eur Heart J"},{"key":"2026060107365276400_ehag254-B28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jacc.2023.01.024","article-title":"Association of incident cardiovascular disease with time course and cumulative exposure to multiple risk factors","volume":"81","author":"Domanski","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B29","doi-asserted-by":"publisher","DOI":"10.5551\/jat.65812","article-title":"Joint impact of smoking and metabolic syndrome on cardiovascular disease: a cohort study","author":"Hu","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"2026060107365276400_ehag254-B30","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.jacc.2018.08.2163","article-title":"Healthy behavior, risk factor control, and survival in the COURAGE trial","volume":"72","author":"Maron","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jacc.2025.01.028","article-title":"Guideline-directed medical therapy and outcomes in the ISCHEMIA trial","volume":"85","author":"Maron","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B32","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jacc.2020.02.045","article-title":"Effect of smoking on outcomes of primary PCI in patients with STEMI","volume":"75","author":"Redfors","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026060107365276400_ehag254-B33","doi-asserted-by":"publisher","first-page":"e003370","DOI":"10.1161\/JAHA.116.003370","article-title":"Smoker\u2019s paradox in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"5","author":"Gupta","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026060107365276400_ehag254-B34","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jcin.2024.12.028","article-title":"Smoking status at baseline and 10-year outcomes after drug-eluting stent implantation: insights from the DECADE cooperation","volume":"18","author":"Presch","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"2026060107365276400_ehag254-B35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"key":"2026060107365276400_ehag254-B36","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag254\/68441928\/ehag254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag254\/68441928\/ehag254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:36:58Z","timestamp":1780313818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag254\/8699199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag254","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"ehag254"}}